|Bid||149.01 x 800|
|Ask||149.50 x 1100|
|Day's Range||148.75 - 150.83|
|52 Week Range||141.95 - 226.61|
|Beta (3Y Monthly)||0.97|
|PE Ratio (TTM)||13.78|
|Earnings Date||Aug 1, 2019|
|Forward Dividend & Yield||0.04 (0.03%)|
|1y Target Est||215.61|
When Malachi Anderson was diagnosed with a rare and often deadly disease called spinal muscular atrophy (SMA) as an infant nearly four years ago, his parents Tina and Torence had a decision to make. In years past, many of the babies born with the most severe form of SMA, like Malachi, died before their second birthday. By 2015, drugmakers were testing two experimental therapies in clinical trials: a one-time gene therapy treatment that is now owned by Novartis AG and Spinraza, a Biogen Inc drug which is given through spinal infusion every four months, indefinitely.
On May 21, CNBC's Healthy Returns returned for its second year, featuring interviews, panel discussions and presentations from some of the most influential leaders in health care. Speakers included United Therapeutics CEO Martine Rothblatt, Former FDA Commissioner Scott Gottlieb, Novartis CEO Vasant Narasimhan, Cigna CEO David Cordani, Johnson & Johnson CEO Alex Gorsky. A diverse set of innovative companies were represented, including Verily, Fitbit, Synthego, Kaiser Permanente, insito, Bright Health, Microsoft Health, Livongo and more.
Global health service company Cigna Corporation announced today that Eric Palmer, Executive Vice President and Chief Financial Officer, will present at the Goldman Sachs 40th Annual Global Healthcare Conference on June 12, 2019 in Rancho Palos Verdes, CA.
Cigna Corp NYSE:CIView full report here! Summary * Perception of the company's creditworthiness is neutral * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for CI with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CI. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding CI totaled $10.91 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. CI credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Reports indicate a pair of hedge funds believe Centene can do better than its proposed $17.3B deal for WellCare if it were to find a buyer for itself.
One of the largest healthcare networks in the region is set to end its relationship with Cigna June 14, if new contract terms aren't reached.
The St. Louis-based pharmacy benefits manager is building a digital health formulary to help guide insurers to the most effective digital health tools for their members
Corporate Responsibility Magazine has named global health service company Cigna to its 20th annual 100 Best Corporate Citizens ranking, recognizing outstanding environmental, social and governance transparency and performance among the 1,000 largest publicly traded companies in the United States.
Clayco has named James Havel as executive vice president and CFO, effective Wednesday, the company announced.
On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS ) is a good company. Cramer likes Brink's Company (NYSE: BCO ) and he would buy it at its current ...
Cigna and the Cigna Foundation are contributing $140,000 to the Methodist Healthcare Foundation and the Le Bonheur Children’s Hospital Foundation in Memphis to expand the availability of housing for families with critically ill children, and improve access to behavioral health care. “We help children, adults and families stay connected to each other and to community support networks, and that is even more important during a health challenge, when trusted connections can make a big difference,” said Susan Stith, executive director, Cigna Foundation. Cigna is contributing $90,000 to enable Le Bonheur Children’s Hospital Foundation to help complete the recent expansion of the FedExFamilyHouse that tripled the size of the facility so more families with critically ill children have access to housing near the hospital.
The Zacks Analyst Blog Highlights: Cigna, EOG Resources, Northrop Grumman, Sherwin-Williams and Eaton
With less than two months to go, the consent decree was a big topic of conversation at a gathering of business leaders.
Global health service company Cigna Corporation will be hosting its Investor Day on Friday, May 31, 2019 in New York, NY.
BioDelivery (BDSI) incurs narrower-than-expected loss in Q1. Sales surpass the consensus mark. The company raises guidance for 2019.
Bridges Health Partners LLC, a Clinically Integrated Network, and Cigna have entered into a Collaborative Accountable Care Agreement for Cigna commercial customers in Western Pennsylvania.
When Cigna closed its $54 billion deal in December to buy Express Scripts, it created one of the biggest providers of pharmacy benefits and insurance plans in the United States. Its purpose: to contain costs for employers and to leverage data to create more integrated care for consumers. We ask, how is it going so far? CNBC's Bertha Coombs leads a conversation is David Cordani, president and CEO of Cigna, alongside Tim Wentworth, president of Express Scripts and Cigna Services and former CEO of Express Scripts.